Life ScienceCompany
Juno Therapeutics M&A Summary
Juno Therapeutics has acquired 4 companies of its own.
Juno Therapeutics’ largest acquisition to date was in 2016, when it acquired AbVitro for $78M. Juno Therapeutics has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (75%) and information technology (25%).
Juno Therapeutics Ownership
Who owns Juno Therapeutics?
Juno Therapeutics is owned by Celgene. It was acquired on January 22, 2018.
Juno Therapeutics Business Overview
Where is Juno Therapeutics headquartered?
Juno Therapeutics is headquartered in Seattle, Washington.
How many employees does Juno Therapeutics have?
Juno Therapeutics has 373 employees.
What sector is Juno Therapeutics in?
Juno Therapeutics is a life science company.
When was Juno Therapeutics founded?
Juno Therapeutics was founded in 2013.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity4
- Total Sectors Invested 2
- Total Countries Invested 2